<img alt="" height="1" width="1" />
Regulators pave way for biosimilar drug breakthrough
Reuters
LONDON/ZURICH | Fri Jun 28, 2013 11:35am EDT. LONDON/ZURICH (Reuters) - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid ...
First Copy of J&J's $6 Billion Remicade Wins EMA BackingBloomberg
A Pivotal Decision By European Drug Regulators on Remicade Is Unlikely To ...Forbes
'Biosimilar' drug ruling to hit Big PharmaFinancial Times
NJBIZ -Chicago Tribune -FierceBiotech
all 35 news articles »
More...